新型冠状病毒——最新发现。
The Novel Coronavirus - Latest Findings.
机构信息
Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.
出版信息
Microb Biotechnol. 2020 Jul;13(4):819-828. doi: 10.1111/1751-7915.13592. Epub 2020 May 3.
Abstract
What was initially a lung infection epidemic in the metropolitan area of Wuhan followed by a now contained extension to mainland China has now spread to all continents as a major pandemic with current hotspots in Europe and the USA. This minireview is an update of an earlier report on this novel coronavirus infection (Brüssow, 2020, Microb Biotech 13, 607). I am now summarizing the research literature published between end of February to mid-April 2020.
摘要
最初，武汉市市区发生肺部感染疫情，随后疫情蔓延至中国大陆其他地区，现已在全球范围内蔓延，成为一场主要的大流行病，目前欧洲和美国疫情较为严重。这篇简评是对之前关于新型冠状病毒感染的报告的更新（Brüssow，2020，Microb Biotech 13，607）。我现在总结了 2020 年 2 月底至 4 月中旬发表的研究文献。
相似文献
1
The Novel Coronavirus - Latest Findings.新型冠状病毒——最新发现。
Microb Biotechnol. 2020 Jul;13(4):819-828. doi: 10.1111/1751-7915.13592. Epub 2020 May 3.
2
The Novel Coronavirus - A Snapshot of Current Knowledge.新型冠状病毒——当前知识要点概览。
Microb Biotechnol. 2020 May;13(3):607-612. doi: 10.1111/1751-7915.13557. Epub 2020 Mar 6.
3
Coronavirus Disease 2019 Autopsies and Personal Protective Equipment.2019冠状病毒病尸检与个人防护装备
Arch Pathol Lab Med. 2020 Nov 1;144(11):1295a-1295. doi: 10.5858/arpa.2020-0341-LE.
4
Overcoming Challenges in Coronavirus Disease 19 Translational Research.克服 19 冠状病毒病转化研究中的挑战。
J Infect Dis. 2020 Sep 14;222(8):1254-1255. doi: 10.1093/infdis/jiaa397.
5
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.
6
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.评估静脉用瑞德西韦治疗成人重症 COVID-19 的疗效和安全性：一项 3 期随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.
7
[Characteristics of SARS-CoV-2 and potential pharmacological treatment].[严重急性呼吸综合征冠状病毒2的特征及潜在药物治疗]
Postepy Biochem. 2020 May 9;66(2):83-90. doi: 10.18388/pb.2020_321.
8
Tribute to health workers in China: A group of respectable population during the outbreak of the COVID-19.向中国的卫生工作者致敬：在 COVID-19 疫情期间的一群可敬人群。
Int J Biol Sci. 2020 Mar 15;16(10):1739-1740. doi: 10.7150/ijbs.45135. eCollection 2020.
9
A Review of SARS-CoV-2 and the Ongoing Clinical Trials.SARS-CoV-2 综述及正在进行的临床试验。
Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657.
10
SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence.严重急性呼吸综合征冠状病毒2：一种对人类生存造成严重破坏的病毒病原体的出现。
J Genet. 2020;99(1). doi: 10.1007/s12041-020-01205-x.
引用本文的文献
1
Mining for novel antibiotics in the age of antimicrobial resistance.在抗生素耐药时代挖掘新型抗生素
Microb Biotechnol. 2020 Nov;13(6):1702-1704. doi: 10.1111/1751-7915.13662. Epub 2020 Sep 2.
2
Drug targets for COVID-19 therapeutics: Ongoing global efforts.抗新冠病毒药物靶点：全球努力持续进行中。
J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00067-w.
本文引用的文献
1
Combating COVID-19-The role of robotics in managing public health and infectious diseases.抗击 COVID-19——机器人在公共卫生和传染病管理中的作用。
Sci Robot. 2020 Mar 25;5(40). doi: 10.1126/scirobotics.abb5589.
2
Corrigendum to "Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents" [J Hosp Infect 104 (2020) 246-251].《关于“冠状病毒在无生命表面的持久性及其被消毒剂灭活”的勘误》[《医院感染杂志》104 (2020) 246 - 251]
J Hosp Infect. 2020 Jun 17;105(3):587. doi: 10.1016/j.jhin.2020.06.001.
3
Respiratory virus shedding in exhaled breath and efficacy of face masks.呼气中呼吸道病毒的释放和口罩的效果。
Nat Med. 2020 May;26(5):676-680. doi: 10.1038/s41591-020-0843-2. Epub 2020 Apr 3.
4
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
5
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.利用人血管紧张素转化酶 2 进入 SARS-CoV-2 的结构和功能基础
Cell. 2020 May 14;181(4):894-904.e9. doi: 10.1016/j.cell.2020.03.045. Epub 2020 Apr 9.
6
Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study.新冠疫情期间学校关闭对美国医护人员队伍和净死亡率的影响：建模研究。
Lancet Public Health. 2020 May;5(5):e271-e278. doi: 10.1016/S2468-2667(20)30082-7. Epub 2020 Apr 3.
7
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.中国湖北省以外地区 2019 年冠状病毒病的流行病学和传播动态演变：描述性和建模研究。
Lancet Infect Dis. 2020 Jul;20(7):793-802. doi: 10.1016/S1473-3099(20)30230-9. Epub 2020 Apr 2.
8
Fangcang shelter hospitals: a novel concept for responding to public health emergencies.方仓庇护医院：应对突发公共卫生事件的新理念。
Lancet. 2020 Apr 18;395(10232):1305-1314. doi: 10.1016/S0140-6736(20)30744-3. Epub 2020 Apr 2.
9
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.SARS-CoV-2 和 SARS 冠状病毒受体结合域中高度保守的隐蔽表位。
Science. 2020 May 8;368(6491):630-633. doi: 10.1126/science.abb7269. Epub 2020 Apr 3.
10
Special report: The simulations driving the world's response to COVID-19.特别报道：推动全球应对新冠疫情的模拟分析
Nature. 2020 Apr;580(7803):316-318. doi: 10.1038/d41586-020-01003-6.
Zotero 插件